Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart - PubMed (original) (raw)
Comparative Study
. 2007 Oct 30;116(18):2062-71.
doi: 10.1161/CIRCULATIONAHA.107.709360. Epub 2007 Oct 15.
Affiliations
- PMID: 17938288
- DOI: 10.1161/CIRCULATIONAHA.107.709360
Comparative Study
Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart
Nir Grabie et al. Circulation. 2007.
Abstract
Background: PD-L1 and PD-L2 are ligands for the inhibitory receptor programmed death-1 (PD-1), which is an important regulator of immune responses. PD-L1 is induced on cardiac endothelial cells under inflammatory conditions, but little is known about its role in regulating immune injury in the heart.
Methods and results: Cytotoxic T-lymphocyte-mediated myocarditis was induced in mice, and the influence of PD-L1 signaling was studied with PD-L1/L2-deficient mice and blocking antibodies. During cytotoxic T-lymphocyte-induced myocarditis, the upregulation of PD-L1 on cardiac endothelia was dependent on T-cell-derived interferon-gamma, and blocking of interferon-gamma signaling worsened disease. Genetic deletion of both PD-1 ligands [PD-L1/2(-/-)], as well as treatment with PD-L1 blocking antibody, transformed transient myocarditis to lethal disease, in association with widespread polymorphonuclear leukocyte-rich microabscesses but without change in cytotoxic T-lymphocyte recruitment. PD-L1/2(-/-) mice reconstituted with bone marrow from wild-type mice remained susceptible to severe disease, which demonstrates that PD-L1 on non-bone marrow-derived cells confers the protective effect. Finally, depletion of polymorphonuclear leukocytes reversed the enhanced susceptibility to lethal myocarditis attributable to PD-L1 deficiency.
Conclusions: Myocardial PD-L1, mainly localized on endothelium, is critical for control of immune-mediated cardiac injury and polymorphonuclear leukocyte inflammation.
Similar articles
- Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, Kelley VR. Lucas JA, et al. J Immunol. 2008 Aug 15;181(4):2513-21. doi: 10.4049/jimmunol.181.4.2513. J Immunol. 2008. PMID: 18684942 Free PMC article. - Tissue expression of PD-L1 mediates peripheral T cell tolerance.
Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH. Keir ME, et al. J Exp Med. 2006 Apr 17;203(4):883-95. doi: 10.1084/jem.20051776. Epub 2006 Apr 10. J Exp Med. 2006. PMID: 16606670 Free PMC article. - The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
Paterson AM, Brown KE, Keir ME, Vanguri VK, Riella LV, Chandraker A, Sayegh MH, Blazar BR, Freeman GJ, Sharpe AH. Paterson AM, et al. J Immunol. 2011 Aug 1;187(3):1097-105. doi: 10.4049/jimmunol.1003496. Epub 2011 Jun 22. J Immunol. 2011. PMID: 21697456 Free PMC article. - T cell checkpoint regulators in the heart.
Grabie N, Lichtman AH, Padera R. Grabie N, et al. Cardiovasc Res. 2019 Apr 15;115(5):869-877. doi: 10.1093/cvr/cvz025. Cardiovasc Res. 2019. PMID: 30721928 Free PMC article. Review. - Role of PD-L1 and PD-L2 in allergic diseases and asthma.
Singh AK, Stock P, Akbari O. Singh AK, et al. Allergy. 2011 Feb;66(2):155-62. doi: 10.1111/j.1398-9995.2010.02458.x. Epub 2010 Aug 17. Allergy. 2011. PMID: 20722638 Free PMC article. Review.
Cited by
- Early allogeneic immune modulation after establishment of donor hematopoietic cell-induced mixed chimerism in a nonhuman primate kidney transplant model.
Little CJ, Kim SC, Fechner JH, Post J, Coonen J, Chlebeck P, Winslow M, Kobuzi D, Strober S, Kaufman DB. Little CJ, et al. Front Immunol. 2024 Jan 22;15:1343616. doi: 10.3389/fimmu.2024.1343616. eCollection 2024. Front Immunol. 2024. PMID: 38318170 Free PMC article. - Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors.
Reyes-Gibby CC, Qdaisat A, Ferrarotto R, Fadol A, Bischof JJ, Coyne CJ, Lipe DN, Hanna EY, Shete S, Abe JI, Yeung SJ. Reyes-Gibby CC, et al. Head Neck. 2024 Mar;46(3):627-635. doi: 10.1002/hed.27604. Epub 2023 Dec 27. Head Neck. 2024. PMID: 38151809 - Previous cardiovascular injury is a prerequisite for immune checkpoint inhibitor-associated lethal myocarditis in mice.
Rubio-Infante N, Castillo EC, Alves-Figueiredo H, Ramos-González M, Salazar-Ramírez F, Salas-Treviño D, Soto-Domínguez A, Lozano O, García-Rivas G, Torre-Amione G. Rubio-Infante N, et al. ESC Heart Fail. 2024 Apr;11(2):1249-1257. doi: 10.1002/ehf2.14614. Epub 2023 Dec 4. ESC Heart Fail. 2024. PMID: 38049390 Free PMC article. - PD-1, gender, and autoimmunity.
Dinesh RK, Hahn BH, Singh RP. Dinesh RK, et al. Autoimmun Rev. 2010 Jun;9(8):583-7. doi: 10.1016/j.autrev.2010.04.003. Epub 2010 Apr 28. Autoimmun Rev. 2010. PMID: 20433954 Free PMC article. Review. - IFNγ-Stimulated B Cells Inhibit T Follicular Helper Cells and Protect Against Atherosclerosis.
Douna H, de Mol J, Amersfoort J, Schaftenaar FH, Kiss MG, Suur BE, Kroner MJ, Binder CJ, Bot I, Van Puijvelde GHM, Kuiper J, Foks AC. Douna H, et al. Front Cardiovasc Med. 2022 Feb 2;9:781436. doi: 10.3389/fcvm.2022.781436. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35187121 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- HL072056/HL/NHLBI NIH HHS/United States
- K08 AI079268-04/AI/NIAID NIH HHS/United States
- K08 AI079268-02/AI/NIAID NIH HHS/United States
- K08 AI079268-03/AI/NIAID NIH HHS/United States
- R01 HL087282/HL/NHLBI NIH HHS/United States
- AI046414/AI/NIAID NIH HHS/United States
- AI56299/AI/NIAID NIH HHS/United States
- AI059610/AI/NIAID NIH HHS/United States
- K08 AI079268/AI/NIAID NIH HHS/United States
- K08 AI079268-01A1/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials